Long-term responders and survivors on pazopanib for soft tissue sarcomas (STS): Subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.
Bernd Kasper
Honoraria - GlaxoSmithKline
Saskia Litière
No relevant relationships to disclose
Sandrine Marreaud
No relevant relationships to disclose
Stefan Sleijfer
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Jaap Verweij
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Expert Testimony - GlaxoSmithKline
Sebastian Bauer
Honoraria - GlaxoSmithKline; Novartis; Pfizer; PharmaMar
Expert Testimony - GlaxoSmithKline (U)
Jan M. Kerst
No relevant relationships to disclose
Winette T.A. Van Der Graaf
No relevant relationships to disclose